# REVIEW_LOG.md — Peer Review Results Log

**Purpose.** Append-only record of every peer-review interaction in the two-supervisor
loop (claude-lead ⇄ codex-lead). Captures both PLAN reviews (before code is written)
and PATCH reviews (after a diff is produced). This is the _subjective_ review lane —
the human/agent judgment pass — and is deliberately separate from the _objective_ gate
in `VERIFY_LOG.md` (maker/checker discipline: the author never self-approves; the other
supervisor reviews).

**How it is used in the loop.**

- When a Supervisor produces a plan → the peer Supervisor reviews it → append a `PLAN_REVIEW` row.
- When a Supervisor produces a patch/diff → the peer Supervisor reviews it → append a `PATCH_REVIEW` row.
- `verdict = changes_requested` MUST spawn a corresponding row in `PATCH_INBOX.md`
  (the `follow_up` cell should name the `item_id`).
- `verdict = approved` is required before the patch may proceed to the objective gate (`VERIFY_LOG.md`).
- Reviewer ≠ author, always. Lane discipline: Claude reviews backend/perf only at a
  high level; Codex reviews FE/UI only at a high level — deep review stays in-lane.

**Run context.** Initial run id: `RUN-20260620-001`. Cycle 0, idle, next_action: bootstrap.

**Rules.**

- Append-only. Never edit or delete an existing row; correct via a new row.
- One row per review event. Newest at the bottom.
- `timestamp` is ISO-8601 local (Asia/Tokyo), e.g. `2026-06-20T14:32:00+09:00`.
- `type` ∈ {`PLAN_REVIEW`, `PATCH_REVIEW`}.
- `reviewer` is the supervisor identity doing the review: `claude-lead` | `codex-lead`.
- `verdict` ∈ {`approved`, `changes_requested`}.
- `findings` — terse summary of what was found (use `—` if none).
- `follow_up` — pointer to the `PATCH_INBOX.md` item_id, BLOCKED task_id, or `—`.

## Schema

| timestamp | task_id | type | reviewer | verdict | findings | follow_up |
| --------- | ------- | ---- | -------- | ------- | -------- | --------- |

## Log

| timestamp                 | task_id             | type         | reviewer   | verdict  | findings                                                                                                                                                      | follow_up                                                     |
| ------------------------- | ------------------- | ------------ | ---------- | -------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------- |
| 2026-06-20T11:47:27+09:00 | F-20260620-001      | PLAN_REVIEW  | codex-lead | approved | Cross-lane request to wire AGENTS.md pointer accepted; chose option A (codex, as AGENTS.md lane owner, makes the edit).                                       | codex commits AGENTS.md → claude verifies acceptance criteria |
| 2026-06-20T11:44:48+09:00 | (scaffold 2986725b) | PATCH_REVIEW | codex-lead | pending  | Reviewing MESSAGE_PROTOCOL.md / README.md / prompts/codex-lead.md / CLAUDE.md pointer for consistency/security/operability (queued behind route-order slice). | awaiting verdict                                              |

| 2026-06-20T11:49:00+09:00 | F-20260620-001 | PATCH_REVIEW | claude-lead | approved | Commit a1c916ac: AGENTS.md pointer present (line 47), docs-only (4 insertions, AGENTS.md only), prettier --check + git diff --check independently re-verified PASS. Acceptance criteria all met. | F-20260620-001 → done (VERIFY_LOG result=pass) |

| 2026-06-20T11:49:27+09:00 | scaffold-review (2986725b) | PATCH_REVIEW | codex-lead | changes_requested | P2 operability: GATE_CONFIG classified full `pnpm test` (~8k) as cheap/every-slice — would stall the loop. No secret/prod/destructive issues in reviewed docs. | PI-001 (PATCH_INBOX) |
| 2026-06-20T11:51:00+09:00 | scaffold-review (PI-001) | PATCH_REVIEW | claude-lead | (author note — not a verdict) | PI-001 addressed by author (claude-lead) in GATE_CONFIG: targeted vitest every slice / full pnpm test before done. Per maker/checker the author does NOT self-approve — re-review requested from codex-lead. | awaiting codex APPROVED |

| 2026-06-20T11:53:52+09:00 | scaffold-review (PI-001) | PATCH_REVIEW | codex-lead | approved | Re-reviewed c8580b23: GATE_CONFIG targeted/full unit-test cadence now matches repo reality. PI-001 resolved. scaffold (2986725b) accepted. | scaffold-review CLOSED |

<!-- APPEND NEW ROWS BELOW THIS LINE — do not edit rows above -->

| 2026-06-20T15:18:00+09:00 | codex-shared-api-contracts (slice8) | PATCH_REVIEW | claude-lead | approved | 共有契約モジュール `src/lib/pharmacy-cooperation/api-contracts.ts` 抽出(DuplicateMap canonical 化)。各 consumer のローカル型と field 単位照合で loosen/取りこぼしなし、billing は狭い view だが route serializer が全 required 返却で regression なし、dead 型 next_cursor 除去安全。fail-closed 強化(billing に runtime 検証)。gate: typecheck/no-unused/eslint PASS、対象 43/43、**フルスイート 8465 passed/1 skipped・赤ゼロ**。pharmacy-cooperation 一段落=gbrain batch writeback トリガー。 | gbrain writeback + commit 段取りへ |
| 2026-06-20T15:10:00+09:00 | codex-correction-request-phi-fix (slice7) | PATCH_REVIEW | claude-lead | approved (PHI, 確信度高) | **実 PHI 漏洩修正**: correction-requests POST が raw row(reason/proposed_value 等)を返していた→toSafeCorrectionRequest() 通過に修正。全経路確認(GET=二重防御/error=固定文字列/audit=長さのみ/PATCH等 route 不在)で残存漏洩なし。allowlist redaction + SafeCorrectionRequestRow 型除外。real redaction 通すテストで回帰捕捉(positive id / negative 患者名/住所/PHI)。赤テスト workflow-content:1185 は GREEN(slice7 と独立)。gate 全 PASS。FixPattern/FailurePattern として gbrain batch writeback 価値高。 | Codex コミット可 / gbrain batch へ |
| 2026-06-20T15:05:00+09:00 | codex-response-schema-slice6 | PATCH_REVIEW | claude-lead | approved | admin createPartner/createPartnership/activatePartnership/createContract の response-schema 化 + slice5 minor(save malformed-2xx test)対応。bare row(201)を bare schema で正しく検証、include/projection をサーバ実形と突合 OK、effective_from nullable 区別正確。reject テスト8件(固定 fallback toast assert + success 非呼出 + 副作用抑止)。target 単独 14/14 PASS、typecheck/no-unused/eslint PASS。申し送り: (1)別レーンの赤テスト workflow-content.test.tsx:1185、(2)gate ラッパ `echo TEST_EXIT=$?` が vitest 非ゼロ exit をマスク。 | Codex コミット可 / 申し送り2件 Codex へ |
| 2026-06-20T14:52:00+09:00 | codex-response-schema-slice5 | PATCH_REVIEW | claude-lead | approved | admin pharmacy-cooperation contract document preview/save の response-schema 化。preview は success() 非ラップ shape を直接 schema 化(apiDataSchema 包まず)で正しい、save は flat 201 shape 一致。schema ⊆ server(zod strip)で false reject なし、PHI 非露出(throw fallbackMessage のみ)、cursorPaginatedPageSchema 再利用。gate: typecheck/no-unused/eslint PASS、test 全 suite green(8446 passed)。minor 1件=malformed-2xx reject テスト欠落(任意 follow-up)。 | Codex コミット → minor は follow-up 可 |
| 2026-06-20T14:38:00+09:00 | codex-response-schema-refactor | PATCH_REVIEW | claude-lead | approved | 4 slice (cursorPaginatedPageSchema / apiDataSchema / workflow mutation+cursor / billing partner-cooperation). fail-closed 確認(client-json.ts:56-75), 重複なし(CursorPaginatedPage<T> + pagination.ts:8 camelCase 契約と一致, 旧 next_cursor は dead field), PHI 漏洩なし(fallbackMessage 全箇所 補間なし固定リテラル), 型一致(any 握り潰しなし). gate: typecheck/typecheck:no-unused/test(2 files 10 tests)/eslint(5 files) 全 PASS. partition clean(対象5ファイルのみ). nit 3件=任意・将来課題. | Codex が自ファイルのみ stage でコミット → claude verify |
| 2026-06-20T20:10:00+09:00 | F-20260620-002 | PATCH_REVIEW | codex-lead | approved | Commit c6ee1476 fix(patients): §10 fail-close の2 mutation(POST create/PATCH save)を readApiJson(local minimal apiDataSchema(z.object({id:z.string()})))へ。static fallback(status.label補間除去)、unknown strip で raw row 非到達。malformed-2xx テスト2件(success toast/invalidate 不発を spy 検証)+ 既存 create mock を new Response 化(readApiJson は text() 経由)。codex 独立再検証 GREEN(vitest 6/6 / typecheck / no-unused / eslint / format:check / git diff --check)。partition clean(locked 2ファイルのみ)。route-side safe projection は F-20260620-003(codex lane)へ分離。 | F-20260620-002 → done; F-20260620-003 codex lane 残 |
| 2026-06-20T19:05:00+09:00 | codex-hardening-slice-precommit (78 dirty paths) | PATCH_REVIEW | claude-lead | approved | **pre-commit review** (codex held commit for PHI/security). 6 次元 fan-out (Workflow wf_ca30bab6-348) + material findings adversarial verify。14 findings / **0 blocker / 0 PHI漏洩 / 0 正確性欠陥**。コード6件は全て肯定的確認: §9 PHI対称性 HOLDS(correction-requests POST=toSafeCorrectionRequest, raw row なし)、§10 fail-closed(readApiJson schema, fallback 固定)、print-audit **IDOR なし**(server-scoped {id,org_id,confirmed} + client id-match 486/510/744/848)・null content 409+superRefine・fresh audit(per-mount runId/staleTime0/refetchOnMount always/re-POST)。削除コンポーネント(patient-workspace-rail/pharmacist-memo-tab/PatientDocumentsPanel)=git grep 参照ゼロで削除安全(独立 spot-check)。gate codex 提示=8504 tests/build GREEN。非blocking follow-up 1件(low, 範囲外): patient-documents-panel.tsx ~344/654 の raw res.json() fail-open(toast/invalidate のみ, PHI 非描画)。 | 条件=commit-hygiene split(6コミット案+do-not-stage list)を PATCH_REVIEW_RESULT で送付。gbrain ReviewFinding 書込予定 |
| 2026-06-20T21:12:00+09:00 | F-20260620-003 | PATCH_REVIEW | claude-lead | approved | Commit ec241ffe fix(api): first-visit-document mutation レスポンスを §9 安全射影 `{ id, updated_at }` へ。実 diff 精査: 新 helper toSafeFirstVisitDocumentMutationResponse は id+updated_at のみ返却(spread なし, Date→ISO)、POST(294)+PATCH([id]:236) 両方適用、他の success() は GET list(route.ts:132, read-path で by-design・範囲外)のみ=raw mutation leak なし。テスト exact toEqual{id,updated_at} + not.toHaveProperty(emergency_contacts/delivered_to/document_url) で将来 re-leak 捕捉。F-002 互換(id 保持)。独立再検証: partition CLEAN(5 locked paths のみ)+ focused vitest 31/31 pass。codex gate 8506 GREEN。RESEND と承認行き違いあり=再 ACK 済。 | F-20260620-003 → done。§9-on-mutations の昇格候補(PROMOTION_QUEUE, human-gated) |
| 2026-06-20T19:36:32+09:00 | F-20260620-004 | PLAN_REVIEW | codex-lead | changes_requested | 初回 plan は metrics + billing analytics の false-empty 修正方針と ErrorState 再利用は妥当だったが、同一 analytics 画面の resource-map query 失敗も 0/空表示へ倒れる同一 bug class で漏れていた。subagent 3本(code_mapper/frontend_reviewer/test_architect) + 直接コード確認で、resource-map section error/refetch、metrics 404 placeholder 維持、URL 分岐 fetch test、loading status a11y を要求。 | rev2 plan requested |
| 2026-06-20T19:38:32+09:00 | F-20260620-004 | PLAN_REVIEW | codex-lead | approved | Rev2 plan は metrics 非404失敗、analytics billing query 失敗、analytics resource-map query 失敗を section-scoped ErrorState + retry で分離し、404 placeholder/success path を保護するテスト計画まで反映。API/lib/server/prisma 不触、既存 ErrorState 再利用、新 component/hook/type なし。 | Claude may LOCK approved 4 paths and implement |
| 2026-06-20T20:57:30+09:00 | F-20260620-007 | PATCH_REVIEW | codex-lead | changes_requested | /statistics patch は承認済み 64-surface 契約に対して 22 navigable links の自己整合テストのみで、malformed-2xx、stale refetch、raw error/PHI 非表示、org hydration、低権限 metadata 露出のテスト/設計も不足。frontend/test/privacy subagents + focused vitest 18/18 PASS(ただし契約未固定)で判定。 | rev6 plan requested; PATCH_INBOX row pending |
| 2026-06-20T21:05:00+09:00 | F-20260620-007 | PLAN_REVIEW | codex-lead | changes_requested | rev6 の 23 navigable-page 契約は条件付きで妥当だが、64 raw recon→23 manifest の恒久照合、現 22 件から /admin/jobs を含む 23 件化、exact manifest tests、canViewDashboard page gate、per-surface permission filtering が必要。spec/privacy subagents + gbrain prior decisions used。 | rev7 plan requested |
| 2026-06-20T21:43:05+09:00 | F-20260620-007 | PATCH_REVIEW | codex-lead | changes_requested | rev7 dirty diff reviewed with spec/security/test subagents + direct verification. Focused vitest/eslint/typecheck/format/build were GREEN, but five blockers remain: KPI client expects `{data}` while dispensing-stats API returns raw fields, clerk-support card uses canVisit though destination requires canViewDashboard, reports analytics card uses canVisit though destination requires canSendCareReport, exact 23-entry manifest/provenance contract is not frozen, and StatisticsPage auth/prisma/filtering glue lacks integration coverage. gbrain ReviewFinding written: projects/careviax/reviews/statistics-hub-rev7-contract-permission-api-mismatch-20260620. | PI-002 |
| 2026-06-21T00:23:30+09:00 | F-20260620-009 | PATCH_REVIEW | codex-lead | changes_requested | rev2 command-palette diff reviewed with frontend/a11y/security focus plus focused Vitest 8 files PASS. Required fixes: short-query below MIN_CHARS must not expose stale rows or allow Enter navigation; AppShell must not swallow Escape while palette dialog is open; visible copy must not promise deferred prescription/contact categories until F-010A follow-up re-enables them. Security addendum: prescription/contact remain deferred until minimal backend contracts are used. | PI-003 |
